DynamiCure Biotechnology
Igor Proscurshim is a seasoned healthcare professional with extensive experience in clinical development, particularly in oncology and immuno-oncology. Currently serving as Vice President of Clinical Development at DynamiCure Biotechnology, Igor previously held similar leadership roles at Ichnos Sciences and Takeda Oncology, overseeing innovative therapies and the strategic development of clinical programs. Igor has contributed to significant projects, such as the clinical development of bispecific antibodies and novel oncolytic virus therapies. Earlier career experiences include co-founding Intelligent Health LLC, serving as Chief Scientific Officer at Recepta Biopharma, and coordinating colorectal cancer screening programs in Brazil. Igor holds an MD from the University of São Paulo and has completed a General Surgery Residency there.
This person is not in the org chart
This person is not in any teams
DynamiCure Biotechnology
Driven by science and passionate about advancing patient care, DynamiCure is translating breakthrough insights on immuno-normalization into a pipeline of innovative antibody candidates with first-in-class and best-in-class potential to treat cancer, autoimmune, and other diseases. Our core values - Empathy, Dedication, Collaboration, Transparency - are at the heart of everything we do, inspired by each other and our partners to provide patients worldwide with access to new therapeutics.